The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Voyager Therapeutics, Inc(NASDAQ:VYGR) 
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's ...
Website: http://www.voyagertherapeutics.com
Founded: 2013
Full Time Employees: 185
Sector: Healthcare
Industry: Biotechnology
Voyager Therapeutics Days Payable Outstanding ttm (DPO)
Voyager Therapeutics Days Receivable Outstanding ttm (DSO)
Voyager Therapeutics Op Cashflow Per Share ttm
Voyager Therapeutics Free Cashflow Per Share ttm
Voyager Therapeutics Cash Per Share ttm
Voyager Therapeutics P/S ratio ttm
Voyager Therapeutics (GAAP) P/E ratio ttm
Voyager Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.